Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference

Fortrea (Nasdaq: FTRE) updated its presentation time at the J.P.

Rhea-AI Summary

Fortrea (Nasdaq: FTRE) updated its presentation time at the J.P. Morgan Annual Healthcare Conference to 11:15 am PST on Tuesday, January 13, 2026. CEO Anshul Thakral, CFO Jill McConnell, and SVP of Investor Relations Tracy Krumme will participate. A live webcast and replay will be available via the company’s Investor Relations "Events" page. Investors seeking one-on-one meetings should contact their banking representatives.

Argus Jan 9 session

-0.29% close to close Open Argus

Details

News Market Reaction – FTRE

On Jan 9, the day this news came out, FTRE closed 0.29% below the previous close.

Data tracked by StockTitan Argus for the Jan 9 session.

Market Context

This announcement updates Fortrea’s presentation time to 11:15 am PST on January 13, 2026 at the J.P...

Analysis

This announcement updates Fortrea’s presentation time to 11:15 am PST on January 13, 2026 at the J.P. Morgan Healthcare Conference, reiterating webcast access and optional one-on-one meetings via banking representatives. It follows a series of conference appearances and investor-focused communications in recent months. Investors tracking the story may focus more on any commentary delivered at the conference and on ongoing execution against prior financial and strategic disclosures than on this scheduling change itself.

Key Figures

Presentation time: 11:15 am PST Presentation date: January 13, 2026

Presentation time

11:15 am PST

J.P. Morgan Annual Healthcare Conference presentation slot

Presentation date

January 13, 2026

Scheduled conference appearance in San Francisco

Historical Context

5 past events · Latest: Jan 06

5 events

1. Jan 06

   Conference participation

   24h Move

   +5.5%

   Announced J.P. Morgan conference presentation and webcast access details.

2. Dec 10

   Equity inducement awards

   24h Move

   +5.2%

   Granted 245,000 RSUs to new hires under inducement plan.

3. Dec 04

   Strategic collaboration

   24h Move

   -0.7%

   Announced SCTbio collaboration to align CDMO and CRO services.

4. Nov 25

   Conference participation

   24h Move

   +7.0%

   Outlined CEO/CFO participation in Citi and Evercore conferences.

5. Nov 24

   Debt tender offer

   24h Move

   +9.6%

   Completed $75.743M senior notes tender funded with cash on hand.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

contract research organization

1 terms

contract research organization technical

"Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO)"

A contract research organization (CRO) is an outside company hired to run medical and scientific work for drug, device or biotech developers—like an experienced project manager and lab team that companies rent instead of building in-house. Investors care because CROs influence development speed, quality and cost: delays or successes in trials affect client spending, regulatory risk and ultimately revenues for both the sponsor and the CRO.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DURHAM, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced an updated presentation time of 11:15 am PST on Tuesday, January 13, 2026, at the J.P. Morgan Annual Healthcare Conference (San Francisco).

CEO Anshul Thakral, CFO Jill McConnell, and SVP of Investor Relations, Tracy Krumme will participate in the conference. The live webcast and replay can be accessed through the “Events” section of Fortrea’s  Investor Relations website. Investors interested in one-on-one meetings should contact their banking representatives.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).

Fortrea Contacts:

Tracy Krumme (Investors) – 984-385-6707, Tracy.Krumme@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Fortrea (FTRE) present at the J.P. Morgan Healthcare Conference?

Fortrea will present on Tuesday, January 13, 2026 at 11:15 am PST.

Who from Fortrea (FTRE) will speak at the January 13, 2026 presentation?

CEO Anshul Thakral, CFO Jill McConnell, and SVP Investor Relations Tracy Krumme will participate.

How can investors watch Fortrea’s (FTRE) J.P. Morgan presentation?

A live webcast and replay will be accessible through Fortrea’s Investor Relations "Events" page.

How can investors request one-on-one meetings with Fortrea (FTRE) at the conference?

Investors should contact their banking representatives to request one-on-one meetings.

Where is the J.P. Morgan Annual Healthcare Conference presentation taking place for Fortrea (FTRE)?

The presentation is part of the J.P. Morgan Annual Healthcare Conference in San Francisco.